Stocks and Investing Stocks and Investing
Wed, March 13, 2024
Tue, March 12, 2024

David Nierengarten Upgraded (ANAB) to Buy and Increased Target to $34 on, Mar 12th, 2024


Published on 2024-10-28 09:38:26 - WOPRAI, David Nierengarten
  Print publication without navigation


David Nierengarten of Wedbush, Upgraded "AnaptysBio, Inc." (ANAB) to Buy and Increased Target from $20 to $34 on, Mar 12th, 2024.

David has made no other calls on ANAB in the last 4 months.



There are 3 other peers that have a rating on ANAB. Out of the 3 peers that are also analyzing ANAB, 0 agree with David's Rating of Hold.



These are the ratings of the 3 analyists that currently disagree with David


  • Julian Harrison of "BTIG" Initiated at Strong Buy and Held Target at $55 on, Monday, February 26th, 2024
  • Alex Schwartz of "Stifel" Initiated at Strong Buy and Held Target at $50 on, Wednesday, February 21st, 2024
  • Yasmeen Rahimi of "Piper Sandler" Initiated at Buy and Held Target at $80 on, Friday, February 16th, 2024
Contributing Sources